TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
HALO

Halozyme Therapeutics Inc

Healthcare · Biotechnology

110.80$ +1.0% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow HALO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.39 -0.29 -0.39 0.96 -0.34 -0.59 0.39 2.04 1.71 2.90 3.70 5.26
0.01 0.01 0.02 0.02 0.02 0.03 0.02 0.02 0.35 0.63 0.63 0.71
0.12 0.16 0.20 0.22 0.25 0.24 0.12 0.14 0.17 0.27 0.34 0.42
0.13 0.17 0.26 0.33 0.25 0.25 0.12 -0.77 0.48 – – –
0.00 -0.23 0.13 0.15 -0.04 -0.35 -0.77 0.03 -0.79 -0.29 -1.05 -1.23
0.01 0.02 0.02 0.01 0.03 0.03 0.02 0.01 0.03 0.11 0.08 0.06
-0.27 0.05 -0.60 -1.18 0.02 -0.04 0.55 -2.77 -3.46 -0.72 -2.03 -4.41
0.00 0.00 0.00 0.00 – 0.10 0.45 0.09 – 0.10 – –
0.93 0.10 0.01 1.06 0.10 -1.39 -1.06 -2.38 -1.42 -3.00 -1.93 -2.76
1.21 1.17 1.16 -0.12 -0.54 2.35 -0.14 2.83 4.39 -0.10 0.00 3.64
0.93 0.10 1.18 0.95 -0.44 1.06 -0.75 0.53 2.58 -3.04 -1.69 -0.69
0.28 -0.14 0.18 0.73 -0.77 0.43 0.19 -0.20 0.82 -0.87 -0.02 0.17
-0.40 -0.31 -0.42 0.95 -0.38 -0.62 0.37 2.03 1.67 2.78 3.62 5.20

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?